1. bookVolumen 65 (2015): Edición 2 (June 2015)
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

Immunomodulatory effects of inosine pranobex on cytokine production by human lymphocytes

Publicado en línea: 23 May 2015
Volumen & Edición: Volumen 65 (2015) - Edición 2 (June 2015)
Páginas: 171 - 180
Aceptado: 20 Nov 2014
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés

1. D. M. Campoli-Richards, E. M. Sorkin and R. C. Heel, Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, Drugs 32 (1986) 383-424.10.2165/00003495-198632050-00001Search in Google Scholar

2. H. Ohnishi, H. Kosuzume, H. Inaba, M. Ohkura, S. Shimada and Y. Suzuki, The immunomodulatory action of inosiplex in relation to its effects in experimental viral infections, Int. J. Immunopharmacol. 5 (1983) 181-196.10.1016/0192-0561(83)90055-3Search in Google Scholar

3. H. Ohnishi, H. Kosuzume, H. Inaba, M. Okura, Y. Morita, H. Mochizuki and Y. Suzuki, Mechanism of host defence suppression induced by viral infection: mode of action of inosiplex as an antiviral agent, Infect. Immun. 38 (1982) 243-250.Search in Google Scholar

4. K. Y. Tsang, H. H. Fudenberg and M. J. Gnagy, Restoration of immune response of aging hamsters by treatment with isoprinosine, J. Clin. Invest. 71 (1983) 1750-1755; DOI: 10.1A2/JCI110930.10.1172/JCI110930Search in Google Scholar

5. J. Gutierrez, R. S. Issacson and B. S. Koppel, Subacute sclerosing panencephalitis: an update, Dev. Med. Child. Neurol. 52 (2010) 901-907; DOI: 10.1111/j.1469-8749.2010.03717.x.10.1111/j.1469-8749.2010.03717.xSearch in Google Scholar

6. C. Pedersen, E. Sandstrocm, C. S. Petersen, G. Norkrans, J. Gerstoft , A. Karlsson, K. C. Christensen, C. Hakanson, P. Pehrson, J. O. Nielsen, H. J. Jucrgensen, and Scandinavian Isoprinosine Study Group, The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection, New Engl. J. Med. 322 (1990) 1757-1763; DOI: 10.1056/NEJM199006213222501.10.1056/NEJM199006213222501Search in Google Scholar

7. T. Nakamura, N. Miyasaka, R. M. Pope, N. Talal and I. J. Russell, Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases, Clin. Exp. Immunol. 52 (1983) 67-74.Search in Google Scholar

8. J. W. Hadden, E. M. Hadden and R. G. Coffey, Isoprinosine augmentation of phytohemagglutinininduced lymphocyte proliferation, Infect. Immun. 13 (1976) 382-387.10.1128/iai.13.2.382-387.1976Search in Google Scholar

9. J. Litzman, J. Lokaj, M. Krejci, S. Pesak and G. Morgan, Isoprinosine does not protect against frequent respiratory tract infections in childhood, Eur. J. Pediatr. 158 (1999) 32-37.10.1007/s004310051005Search in Google Scholar

10. M. Gołębiowska-Wawrzyniak, K. Markiewicz, A. Kozar, P. Derentowicz, J. Czerwińska-Kartowicz, K. Jastrzębska-Janas, J. Wacławek, Z. M. Wawrzyniak and H. Siwinska-Gołębiowska, Immunological and clinical study on the therapeutic efficacy of inosine pranobex, Pol. Merkur. Lekarski 19 (2005) 379-382.Search in Google Scholar

11. P. Hersey and A. Edwards, Effect of isoprinosine on natural killer cell activity of blood mononuclear cells in vitro and in vivo, Int. J. Immunopharmacol. 6 (1984) 315-320; DOI: 10.1016/0192-0561(84)90048-1.10.1016/0192-0561(84)90048-1Search in Google Scholar

12. S. Milano, M. Dieli, S. Millott , M. D. Miceli, E. Maltese and E. Cillari, Effect of isoprinosine on IL-2, IFN-γ and IL-4 production in vivo and in vitro, Int. J. Immunopharmacol. 13 (1991) 1013-1018; DOI: 10.1016/0192-0561(91)90055-C.10.1016/0192-0561(91)90055-CSearch in Google Scholar

13. S. Jiang and C. Dong, A complex issue on CD4+ T-cell subsets, Immunol. Rev. 252 (2013) 5-11; DOI: 10.1111/imr.12041.10.1111/imr.1204123405891Search in Google Scholar

14. S. McHugh, J. Deighton, I. Rifkin and P. Ewan, Kinetics and functional implications of Th1 and Th2 cytokine production following activation of peripheral blood mononuclear cells in primary culture, Eur. J. Immunol. 26 (1996) 1260-1265; DOI: 10.1002/eji.1830260612.10.1002/eji.18302606128647202Search in Google Scholar

15. B. Perussia, The cytokine profile of resting and activated NK cells, Methods 9 (1996) 370-378; DOI: 10.1084/jcm.20032058.Search in Google Scholar

16. M. Akdis, J. Verhagen, A. Taylor, F. Karamloo, C. Karagiannidis, R. Crameri, S. Thunberg, G. Deniz, R. Valenta, H. Fiebig, C. Kegel, R. Disch, C. B. Schmidt-Weber, K. Blaser and C. A. Akdis, Immune response in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells, J. Exp. Med. 199 (2004) 1567-1575.10.1084/jem.20032058221178215173208Search in Google Scholar

17. I. Striz, E. Brabcova, L. Kolesar and A. Sekerkova, Cytokine networking of innate immunity cells: a potential target of therapy, Clin. Sci. 126 (2014) 593-612; DOI: 10.1042/CS20130497.10.1042/CS2013049724450743Search in Google Scholar

18. B. K. Pedersen, N. Tvede, M. Diamant, J. Gerstoft , M. Bagge Hansen, P. M. Haahr, M. Hording, M. Kappel, M. Klokker, B. Soeberg and P. Skinhoj, Effects of isoprinosine treatment of HIV-positive patients on blood mononuclear cell subsets, NK- and T-cell function, tumor necrosis factor, and interleukins 1, 2, and 6, Scand. J. Immunol. 32 (1990) 641-649.10.1111/j.1365-3083.1990.tb03206.x1702899Search in Google Scholar

19. M. Petrova, D. Jelev and Z. Krastev, Isoprinosine affects serum cytokine levels in healthy adults, J. Interferon Cytokine Res. 30 (2010) 223-227; DOI: 10.1089/jir.2009.0057.10.1089/jir.2009.005720038210Search in Google Scholar

20. R. Sabat, G. Grutz, K. Warszawska, S. Kirsch, E. Witte, K. Wolk and J. Geginat, Biology of interleukin-10, Cytokine Growth Factor Rev. 21 (2010) 331-344; DOI: 1016/j.cytogfr.2010.09.002.10.1016/j.cytogfr.2010.09.00221115385Search in Google Scholar

21. A. Langkjaer, B. Kristensen, B. E. Hansen, H. Schultz, L. Hegedus and C. H. Nielsen, B-cell exposure to self-antigen induces IL-10 producing B cells as well as IL-6- and TNF-α-producing B-cell subsets in healthy humans, Clin. Immunol. 145 (2012) 1-10; DOI: 10.1016/j.clim.2012.07.004.10.1016/j.clim.2012.07.00422885146Search in Google Scholar

22. M. Saraiva and A. O’Garra, The regulation of IL-10 production by immune cells, Nat. Rev. Immunol. 10 (2010) 170-181; DOI: 10.103/nri2711.10.1038/nri271120154735Search in Google Scholar

23. G. Del Prete, M. De Carli, F. Almerigogna, M. G. Giudizi, R. Biagotti and S. Romagnani, Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation an cytokine production, J. Immunol. 150 (1993) 353-360.10.4049/jimmunol.150.2.353Search in Google Scholar

24. S. Gregori, K. S. Goudy and M. G. Roncarolo, The cellular and molecular mechanisms of immunosuppression by human type 1 regulatory T cells, Front. Immunol. 3 (2012), article 30; DOI: 10.3389/ fimmu.2012.00030.Search in Google Scholar

25. A. A. Navarini, M. Recher, K. S. Lang, P. Georgiev, S. Meury, A. Bergthaler, L. Flatz, J. Bille, R. Landmann, B. Odermatt , H. Hengartner and R. M. Zinkernagel, Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses, PNAS 103 (2006) 15335-15539; DOI: 10.1073/pnas.0607225103.Search in Google Scholar

26. W. W. Metzger and K. Sun, Immune dysfunction and bacterial coinfections following influenza, J. Immunol. 191 (2013) 2047-2052; DOI: 10.4049/jimmunol.1301152.10.4049/jimmunol.1301152376023523964104Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo